• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI EvidencePulse™
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI EvidencePulse™
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

Both intestinal ultrasound and magnetic resonance imaging can assess radiologic stricturing in Crohn’s disease

bySimon PanandAlex Chan
May 14, 2025
in Chronic Disease, Gastroenterology, Imaging and Intervention
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. Intestinal ultrasound (IUS) and magnetic resonance imaging (MRI) were effective imaging modalities for the assessment of the radiologic response of stricturing Crohn’s disease to treatment. 

Evidence Rating Level: 1 (Excellent)

In recent years, transmural healing has become a major treatment target in the management of Crohn’s disease. While such healing relies on imaging for assessment, there is a paucity of data examining the role of IUS in the monitoring of stricturing Crohn’s disease and time and cost remain significant barriers to access for MRI. This study, an analysis of secondary outcomes of the STRIDENT (Stricture Definition and Treatment) trial, therefore sought to investigate the role of MRI and IUS in monitoring the response of stricturing Crohn’s disease to treatment. 77 patients (median[IQR] age, 45[29-53] years) were included in the trial with all 77 receiving baseline IUS and MRI. Among baseline IUS scans, 59 were good quality with visible strictures. Among baseline MRIs, 72 had visible strictures. Stricture resolution on IUS occurred in 17/59 (29%) of patients, while stricture resolution on MRI occurred in 16/72 (22%) of patients. When comparing stricture resolution on IUS and MRI, there was a strong association (χ21(n = 59) = 41.19, Cramer’s V ϕ=0.84; P < .001). When comparing with endoscopy, there was a relatively strong association between stricture resolution on MRI and passable strictures visible on endoscopy (χ21(n = 64) = 10.54, Cramer’s V ϕ=0.41; P = .002). Overall, this study showed that MRI and IUS are effective imaging modalities in the assessment of the radiologic response of stricturing Crohn’s disease to treatment.  

Click to read the study in IBD

Image: PD

©2025 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc. 

RELATED REPORTS

Ustekinumab may be superior to Vedolizumab for the treatment of Crohn’s disease

mFOLFIRINOX may have a limited role in pancreatic cancer in Phase II/III trial

Guselkumab is safe and effective in patients with moderate-to-severe Crohn’s disease

Tags: crohn'sCrohn's DiseaseGastroenterologyIBDinflammatory bowel disease
Previous Post

FDA Approves Dupilumab for Chronic Spontaneous Urticaria

Next Post

Eli Lilly Takes Legal Action Against Telehealth Startups

RelatedReports

Biosimilar to infliximab shows equivalent safety and efficacy for treating Crohn’s disease
Chronic Disease

Ustekinumab may be superior to Vedolizumab for the treatment of Crohn’s disease

August 8, 2025
Rectal indomethacin dose escalation for prevention of pancreatitis after endoscopic retrograde cholangiopancreatography in high-risk patients
Gastroenterology

mFOLFIRINOX may have a limited role in pancreatic cancer in Phase II/III trial

August 7, 2025
Unenhanced magnetic resonance imaging highly sensitive and specific for acute appendicitis
Chronic Disease

Guselkumab is safe and effective in patients with moderate-to-severe Crohn’s disease

August 7, 2025
Quick Take: Combined Surgery and Extensive Intraoperative Peritoneal Lavage vs Surgery Alone for Treatment of Locally Advanced Gastric Cancer: The SEIPLUS Randomized Clinical Tria
Gastroenterology

Randomized Phase III trial of Ramucirumab finds benefit for patients with refractory advanced gastric cancer

August 2, 2025
Next Post
Food environment associated with gestational diabetes

Eli Lilly Takes Legal Action Against Telehealth Startups

Physical therapy vs. glucocorticoid injection in patients with meniscal tears and knee osteoarthritis

Quick Take: Effect of Pregabalin on Radiotherapy-Related Neuropathic Pain in Patients With Head and Neck Cancer: A Randomized Controlled Trial

Novartis and Sanofi Urge EU to Raise Drug Prices

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Medical cannabis has a high discontinuation rate for treatment of musculoskeletal pain
  • #VisualAbstract: Riociguat Improves Exercise Following Balloon Pulmonary Angioplasty in Patients with Pulmonary Hypertension
  • FDA Approves First-Ever Treatment for Non-Cystic Fibrosis Bronchiectasis
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2025 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI EvidencePulse™
  • Pharma
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2025 2 Minute Medicine, Inc. - Physician-written medical news.